TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target.
Saved in:
| Title: | TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target. |
|---|---|
| Authors: | Kennedy E; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom., Coulter E; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Department of Haemato-Oncology, Division of Cancer Studies, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom., Halliwell E; UCL Great Ormond Street Institute of Child Health, London, United Kingdom., Profitos-Peleja N; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain., Walsby E; Cardiff CLL Research Group, Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom., Clark B; Molecular Pathology Laboratory, King's College Hospital, London, United Kingdom., Phillips EH; Department of Haemato-Oncology, Division of Cancer Studies, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Burley TA; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom., Mitchell S; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom., Devereux S; Department of Haemato-Oncology, Division of Cancer Studies, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom., Fegan CD; Cardiff CLL Research Group, Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom., Jones CI; Department of Primary Care and Public Health, Brighton and Sussex Medical School, Falmer, United Kingdom., Johnston R; Department of Haematology, Brighton and Sussex University Hospital Trust, Brighton, United Kingdom., Chevassut T; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom.; Department of Haematology, Brighton and Sussex University Hospital Trust, Brighton, United Kingdom., Schulz R; German Cancer Research Centre (DKFZ), Heidelberg, Germany., Seiffert M; German Cancer Research Centre (DKFZ), Heidelberg, Germany., Agathanggelou A; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; and., Oldreive C; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; and., Davies N; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; and., Stankovic T; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; and., Liloglou T; Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom., Pepper C; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom., Pepper AGS; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom. |
| Source: | Blood [Blood] 2021 Jun 03; Vol. 137 (22), pp. 3064-3078. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
